- Home
- PPIH vs LRMR Comparison
PPIH vs LRMR Comparison
Compare PPIH & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPIH
- LRMR
- Stock Information
- Founded
- PPIH 1993
- LRMR N/A
- Country
- PPIH United States
- LRMR United States
- Employees
- PPIH 750
- LRMR N/A
- Industry
- PPIH Pollution Control Equipment
- LRMR Biotechnology: Pharmaceutical Preparations
- Sector
- PPIH Industrials
- LRMR Health Care
- Exchange
- PPIH Nasdaq
- LRMR Nasdaq
- Market Cap
- PPIH 217.1M
- LRMR 204.9M
- IPO Year
- PPIH N/A
- LRMR N/A
- Fundamental
- Price
- PPIH $27.04
- LRMR $4.21
- Analyst Decision
- PPIH
- LRMR Strong Buy
- Analyst Count
- PPIH 0
- LRMR 7
- Target Price
- PPIH N/A
- LRMR $17.86
- AVG Volume (30 Days)
- PPIH 84.5K
- LRMR 1.7M
- Earning Date
- PPIH 09-10-2025
- LRMR 08-14-2025
- Dividend Yield
- PPIH N/A
- LRMR N/A
- EPS Growth
- PPIH N/A
- LRMR N/A
- EPS
- PPIH 1.55
- LRMR N/A
- Revenue
- PPIH $170,810,000.00
- LRMR N/A
- Revenue This Year
- PPIH N/A
- LRMR N/A
- Revenue Next Year
- PPIH N/A
- LRMR N/A
- P/E Ratio
- PPIH $17.52
- LRMR N/A
- Revenue Growth
- PPIH 9.96
- LRMR N/A
- 52 Week Low
- PPIH $8.23
- LRMR $1.61
- 52 Week High
- PPIH $28.09
- LRMR $9.50
- Technical
- Relative Strength Index (RSI)
- PPIH 62.67
- LRMR 57.77
- Support Level
- PPIH $25.00
- LRMR $3.42
- Resistance Level
- PPIH $26.92
- LRMR $3.95
- Average True Range (ATR)
- PPIH 1.56
- LRMR 0.33
- MACD
- PPIH 0.19
- LRMR -0.01
- Stochastic Oscillator
- PPIH 85.65
- LRMR 51.90
About PPIH Perma-Pipe International Holdings Inc.
Perma-Pipe International Holdings Inc is engaged in the manufacture and sale of products in the reportable segment of Piping Systems. The company engineers, designs, manufactures, and sells specialty piping systems and leak detection systems. Specialty piping systems include insulated and jacketed district heating and cooling piping systems for efficient energy distribution from central energy plants to multiple locations, primary and secondary containment piping systems for transporting chemicals, hazardous fluids, and petroleum products, and the coating and insulation of oil and gas gathering and transmission pipelines. It operates in the United States, Canada, the Middle East, Europe, India, and other countries.
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.